Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Carbobenzoxy chloride" patented technology

Analysis method for simultaneous detection of amino acids and biogenic amines in foods

The invention belongs to the field of analytical chemistry and particularly relates to an analysis method for simultaneous detection of amino acids and biogenic amines in foods. The method is characterized in that for the first time, 4'-carbonyl chloride-rhodamine is used as a derivatization reagent to realize simultaneous derivatization of the amino acids and the biogenic amines in the food by means of ultrasonic assistance, in-situ derivation and dispersive liquid-liquid microextraction, and qualitative and quantitative detection and analysis are performed by means of ultra-high performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry in multi-reaction monitoring mode. The method can be used for simultaneous analysis and detection of eight amino acids and nine biogenic amines; by adoption of 1,7-diamino heptane as an internal standard substance, contents of the amino acids and the biogenic amines in different foods can be obtained accurately according to an internal standard method for quantification. The method has advantages of simplicity, quickness, high sensitivity, high selectivity and the like, and high recovery rate is achieved. In addition, by the analysis method, accurate and reliable technical means can be provided for food quality assessment and supervision.
Owner:食药环检验研究院(山东)集团有限公司

Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof

The invention relates to an estrogen amino-acid ester compound with antitumor activity as well as a synthetic method thereof, effectively solving the preparation problems of the estrogen amino-acid ester compound with the antitumor activity. The synthetic method comprises the following steps of: dissolving amino acids or small molecule peptides to an aqueous solution of sodium hydroxide or a saturated solution of sodium bicarbonate, dripping carbobenzoxy chloride, making the solution react until the solution is not purple by developing with ninhydrin or carrying out film detection; washing with aether, removing aether, adjusting the pH value of the water phase with hydrochloric acid until milky white solid occurs and extracting with ethyl acetate; washing mixed solution with distilled water and saturated common salt solution, drying with anhydrous magnesium sulfate, carrying out suction filtration, concentrating and purifying; and then, mixing the mixed solution with sterides nucleus and dissolving the mixture to a reaction solvent, adding a condensing agent and a catalyst, supplementing an additional condensing agent, carrying out film detection, filtering, concentrating and purifying, dissolving in a dissolving solvent, adding palladium carbon for catalytic hydrogenation, detecting the film, filtering, concentrating and purifying. The estrogen amino-acid ester compound withantitumor activity, provided by the invention, has favorable water solubility and is superior to 2-methoxyestradiol in the tumor cell resistance action.
Owner:ZHENGZHOU UNIV

Preparation method and applications of oriented immobilized PEGA composite resin

ActiveCN104844710ADoes not affect conformationDoes not affect activityCarrier-bound/immobilised peptides4-nitrobenzyl alcoholTert-Butyloxycarbonyl protecting group
The invention discloses a preparation method and applications of an oriented immobilized PEGA composite resin. The preparation method comprises following steps: 2-amino-6-chloropurine and 4-nitrobenzyl alcohol are taken as raw materials for Williamson ether synthesis so as to obtain 4-nitryl-O6-benzylguanine; 4-nitryl- O6-benzylguanine is subjected to reduction reaction with protection of t-butyloxycarboryl; coupling reaction of an obtained compound with gamma-aminobutyric acid protected by carbobenzoxy chloride is carried out in the presence of ethyl dimethyl carbodiimide and 1-hydroxybenzotriazole; O<6>-benzylguanine derivative modified PEGA resin is obtained via reduction, separation and purification, reaction with PEGA, and deprotection; and transalkylation reaction of the O<6>-benzylguanine derivative modified PEGA resin with a protein containing MGMT label is carried out, so that oriented immobilization on PEGA resin surface via thioether covalent bonds is realized. Reaction of the preparation method is stable; the steps are simple; a stable uniform protein coating with uniform orientation can be formed on solid material surface by a prepared product; and the preparation method is used for preparing reagent kit with specific recognition effects.
Owner:NORTHWEST UNIV

Method for synthesizing N-fluorene methoxycarbonyl-N-trityl-D-glutamine

The invention relates to a synthetic method of N-fluorenylmethoxycarbonyl-N- triphenylmethyl-D-glutamine to solve the current problems of the shortage of D-Gln raw materials and high cost of synthesizing products from the D-Gln. The synthesis includes the following steps: a. D-glutamate and a carbobenzoxy chloride are reacted to get the N-carbobenzoxy-D-glutamate; in an organic solvent N and N-dimethylformamide with the existence of a triethylamine and bromomethyl-benzene, the N-carbobenzoxy-D-glutamate selectively protects an Alpha-carboxyl to get an N-benzyloxycarbonyl-D-benzyl L-glutamate; b. the triethylamine, ethyl chloroformate and ammonia are added to N- benzyloxycarbonyl-D- benzyl L-glutamate organic solvent with a molar ratio of 1:1:2 to 6; after reacted for 6 to 24 hours under a temperature of -20 to 20 DEG C, an N- benzyloxycarbonyl-D-glutaminebenzylester is gotten; c. the product of b, acetate liquor is reacted with a triphenylmethanol under a catalysis of concentrated sulfuric acid, and N- benzyloxycarbonyl-N-triphenylmethyl-D-glutaminebenzylester can be gotten after reacted for 8 to 24 hours under a temperature of 40 to 60 DEG C; d. benzyloxycarbonyl and benzyl are detracted from the product of c to get the N-triphenylmethyl-D-glutamine; e. the product of d is protected by an Fmoc group to get the N-fluorenylmethoxycarbonyl-N-triphenylmethyl-D- glutamine.
Owner:GL BIOCHEM SHANGHAI

Synthesis method of racemic-(3aR,7aR)-5-(t-butyloxycarboryl)-octahydro furan [3,2-c] pyridine-3a- carboxylic acid

The invention relates to a synthesis method of racemic-(3aR,7aR)-5-(t-butyloxycarboryl)-octahydro furan [3,2-c] pyridine-3a-carboxylic acid. The method mainly solves the technical problem that no proper industrial synthesis method exists in the prior art. The method comprises seven steps that: firstly, 2-bromoethanol and ethyl propiolate react in a solvent of methylene dichloride at the room temperature to obtain a compound 2; then, the compound 2 and ethyl cyanoacetate react in a solvent of N, N-dimethyl formamide at the room temperature over the night to obtain a compound 3; the compound 3 is subjected to catalytic hydrogenation to reduce the cyano groups to obtain amino groups; meanwhile, the exchange with the self ester is performed to obtain a compound 4; a compound 5 is obtained through carbobenzoxy chloride on the compound 4; the compound 5 is reduced by borane to obtain a compound 6; finally, the compound 6 uses a palladium hydroxide as a catalyst in ethanol; meanwhile, Boc estolide is added; hydrogen gas is introduced for overnight reaction to obtain a target compound 7; the compound 7 is hydrolyzed by water and lithium hydroxide in a mixed solution of methanol and water; a final target compound 8 is obtained.
Owner:上海药明康德新药开发有限公司 +4

Hypoxic/ROS response type prodrug for blocking pancreatic duct adenocarcinoma innervation through deep penetration

The invention relates to a hypoxic/ROS (reactive oxygen species) responsive prodrug for deeply penetrating and blocking pancreatic duct adenocarcinoma innervation and a preparation method of the prodrug. The preparation method comprises the following steps: (1) reacting N-alpha-fluorenylmethoxycarbonyl-N-epsilon-t-butyloxycarbonyl-L-lysine with 5-amino-1, 3, 4-thiadiazole-2-sulfonamide to obtain (A); reacting (A) with piperidine to obtain (B); (2) dimethyl dithiopropionic acid methane and thionyl chloride are subjected to a reaction, and (C) is obtained; reacting the compound (C) with camptothecin to obtain a compound (D); (3) azobenzene-4, 4-dicarbonyl chloride and lalotinib are subjected to a reaction, and (E) is obtained; (4) reacting maleimide polyethylene glycol with azobenzene-4, 4-dicarbonyl chloride to obtain (F); (F) reacts with (B) to obtain (G); reacting (G) with trifluoroacetic acid to obtain (H); the reaction product (H) sequentially reacts with N6-carbobenzoxy-L-lysine cyclic anhydride and N5-t-butyloxycarboryl-L-ornithine cyclic anhydride, and (I) is obtained; reacting (I) with trifluoroacetic acid, adding (D), and reacting to obtain (J); reacting (J) with hydrobromic acid and acetic acid, adding (F) and iRGD, and reacting to obtain a polymer prodrug (K); the invention also discloses a method for preparing a nano-drug from the polymer prodrug.
Owner:NINGBO UNIV

Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof

The invention relates to an estrogen amino-acid ester compound with antitumor activity as well as a synthetic method thereof, effectively solving the preparation problems of the estrogen amino-acid ester compound with the antitumor activity. The synthetic method comprises the following steps of: dissolving amino acids or small molecule peptides to an aqueous solution of sodium hydroxide or a saturated solution of sodium bicarbonate, dripping carbobenzoxy chloride, making the solution react until the solution is not purple by developing with ninhydrin or carrying out film detection; washing with aether, removing aether, adjusting the pH value of the water phase with hydrochloric acid until milky white solid occurs and extracting with ethyl acetate; washing mixed solution with distilled water and saturated common salt solution, drying with anhydrous magnesium sulfate, carrying out suction filtration, concentrating and purifying; and then, mixing the mixed solution with sterides nucleus and dissolving the mixture to a reaction solvent, adding a condensing agent and a catalyst, supplementing an additional condensing agent, carrying out film detection, filtering, concentrating and purifying, dissolving in a dissolving solvent, adding palladium carbon for catalytic hydrogenation, detecting the film, filtering, concentrating and purifying. The estrogen amino-acid ester compound withantitumor activity, provided by the invention, has favorable water solubility and is superior to 2-methoxyestradiol in the tumor cell resistance action.
Owner:ZHENGZHOU UNIV

A kind of preparation method of chlorinated fatty ether

The invention discloses a preparation method of chlorinated fatty ether, and aims to solve the problem that when the existing method synthesizes 2-propoxyl ethyl chloride, a large amount of sulfur dioxide will be produced, the amount of waste water will be large, and the phase transfer catalyst cannot be recycled and used mechanically, which will cause problems. Produce solid waste pollution, and when triphosgene is used as the chlorinating agent, triphosgene is expensive and is not suitable for large-scale industrial production. The method comprises the following steps: (1) reacting the compound of formula (I) with carbonyl chloride to prepare the compound of formula (II); (2) preparing the compound of formula (III) through decarboxylation reaction. The present invention provides a brand-new route for preparing chlorinated fatty ethers, which has a high yield and can effectively reduce production costs, and only produces HCl, CO2 and a small amount of high-salt wastewater, with less three wastes, is environmentally friendly, has low environmental protection costs, and is environmentally friendly. It can be suitable for preparing chlorinated fatty ethers with various structures, has high application value and broad application prospects, and is worthy of large-scale popularization and application.
Owner:LIER CHEM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products